THE EFFICACY AND SAFETY OF RAVIDASVIR COMBINED WITH DANOPREVIR IN THE 12-WEEK ORAL REGIMEN FOR TREATMENT-NAIVE HCV GENOTYPE 1 ADULT PATIENTS WITHOUT CIRRHOSIS IN CHINA: PHASE II/III CLINICAL TRIALLai Wei,Xiaoyuan Xu,Sujun Zheng,Yujuan Guan,Jifang Sheng,Xingxiang Yang,Yuanji Ma,Yan Huang,Yi Kang,Xiaofeng Wen,Jun Li,Youwen Tan,Qing He,Qing Xie,Maorong Wang,Ping An,Guozhong Gong,Huimin Liu,Qing Ning,Rui Hua,Bo Ning,Wen Xie,Jiming Zhang,Wenxiang Huang,Yongfeng Yang,Minghua Lin,Yingren Zhao,Yanhong Yu,Jidong Jia, Sr. Yang Dongliang,Liang Chen,Sr. Ye Yinong,Yuemin Nan,Zuojiong Gong,Quan Zhang,Peng Hu,FuSheng Wang,Yongguo Li,Dongliang Li,Zhansheng Jia,Jinlin Hou,Chengwei Chen,Jinzi WuHEPATOLOGY（2019）引用 0|浏览33暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
